1082 related articles for article (PubMed ID: 23784946)
1. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
2. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α,25(OH)(2)D(3).
Chen J; Doroudi M; Cheung J; Grozier AL; Schwartz Z; Boyan BD
Cell Signal; 2013 Dec; 25(12):2362-73. PubMed ID: 23896121
[TBL] [Abstract][Full Text] [Related]
3. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
4. New insights on membrane mediated effects of 1α,25-dihydroxy vitamin D3 signaling in the musculoskeletal system.
Doroudi M; Chen J; Boyan BD; Schwartz Z
Steroids; 2014 Mar; 81():81-7. PubMed ID: 24291576
[TBL] [Abstract][Full Text] [Related]
5. Protein-disulfide isomerase-associated 3 (Pdia3) mediates the membrane response to 1,25-dihydroxyvitamin D3 in osteoblasts.
Chen J; Olivares-Navarrete R; Wang Y; Herman TR; Boyan BD; Schwartz Z
J Biol Chem; 2010 Nov; 285(47):37041-50. PubMed ID: 20843786
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Pdia3-dependent 1α,25-dihydroxy vitamin D3 signaling in musculoskeletal cells.
Boyan BD; Chen J; Schwartz Z
Steroids; 2012 Aug; 77(10):892-6. PubMed ID: 22569272
[TBL] [Abstract][Full Text] [Related]
7. Membrane actions of 1α,25(OH)2D3 are mediated by Ca(2+)/calmodulin-dependent protein kinase II in bone and cartilage cells.
Doroudi M; Plaisance MC; Boyan BD; Schwartz Z
J Steroid Biochem Mol Biol; 2015 Jan; 145():65-74. PubMed ID: 25263660
[TBL] [Abstract][Full Text] [Related]
8. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
10. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.
Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
12. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.
Staal A; Birkenhäger JC; Pols HA; Buurman CJ; Vink-van Wijngaarden T; Kleinekoort WM; van den Bemd GJ; van Leeuwen JP
Bone Miner; 1994 Jul; 26(1):27-42. PubMed ID: 7950503
[TBL] [Abstract][Full Text] [Related]
15. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
16. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway.
Staal A; van den Bemd GJ; Birkenhäger JC; Pols HA; van Leeuwen JP
Bone; 1997 Mar; 20(3):237-43. PubMed ID: 9071474
[TBL] [Abstract][Full Text] [Related]
17. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.
Boyan BD; Sylvia VL; McKinney N; Schwartz Z
J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194
[TBL] [Abstract][Full Text] [Related]
18. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells.
Matsumoto T; Igarashi C; Takeuchi Y; Harada S; Kikuchi T; Yamato H; Ogata E
Bone; 1991; 12(1):27-32. PubMed ID: 2054233
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of 1α,25-dihydroxyvitamin D
Li J; Padwa BL; Zhou S; Mullokandova J; LeBoff MS; Glowacki J
J Steroid Biochem Mol Biol; 2018 Mar; 177():103-108. PubMed ID: 28765038
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
